Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 49-64 of 86
Andrew Wilner, MD, FACP, FAAN
Ken Paller, PhD
Andrew Wilner, MD, FACP, FAAN
Bret Stetka, MD
Andrew Wilner, MD, FACP, FAAN
Jerome Lisk, MD
Ilan Wittstein, MD
Jerome Lisk, MD
Jerrold Vitek, MD, PhD
Jerome Lisk, MD
Jerrold Vitek, MD, PhD
David Weisman, MD
Adil Javed, MD PhD
Jerome Lisk, MD
Ilan Wittstein, MD
- NeuroFrontiers
Shedding Light on the Brain After COVID-19: Assessing the Spectrum of Neurological Risk
Andrew Wilner, MD, FACP, FAAN
Jennifer A. Frontera, MD
Andrew Wilner, MD, FACP, FAAN
Jennifer A. Frontera, MD
David Weisman, MD
Mijail D Serruya MD,PhD
David Weisman, MD
Mijail D Serruya MD,PhD
Jerome Lisk, MD
Eric Gantwerker, MD, MMSc, FACS
Andrew Wilner, MD, FACP, FAAN
Ken Tyler, MD
Andrew Wilner, MD, FACP, FAAN
Ken Tyler, MD
Jerome Lisk, MD
Anthony L. Fine, M.D
